Slow IOL insertion affects wound structure

Article

Slow IOL injection affects corneal wound structure, compared to fast IOL insertion.

Slow IOL injection affects corneal wound structure, compared to fast IOL insertion.

The prospective randomized clinical trial. Headed by Dr Masayuki Ouchi, Ouchi Eye Clinic and the Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan, enrolled 80 eyes that underwent phacoemulsification and IOL implantation using a screw-plunger injector.

All patients were randomized into two equal groups. Group F underwent fast IOL insertion and Group S experienced slow IOL insertion. The team compared change in wound-size preoperatively/postoperatively, need for corneal hydration, surgically induced astigmatism (SIA) and optical coherence tomography (OCT) results of the corneal wound structure.

It was discovered that wound size changes were significantly larger in Group S and the OCT results were more prominent. Corneal hydration was needed in 11 eyes in Group F and 40 in Group S.

The study can be found in the Journal of Cataract and Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.